At the end of the latest market close, InspireMD Inc. (NSPR) was valued at $3.92. In that particular session, Stock kicked-off at the price of $3.86 while reaching the peak value of $3.98 and lowest value recorded on the day was $3.85. The stock current value is $4.17.Recently in News on October 13, 2021, InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health. InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system has received a positive opinion from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the French National Authority for Health (HAS) regarding reimbursement in France, and the CGuard EPS is being added to the list of reimbursed medical products (LPPR) effective October 25, 2021. This was the final step to full commercial launch of CGuard EPS following CNEDIMTS’ positive opinion for reimbursement received by the Company on May 11, 2021 for the treatment of symptomatic and non-symptomatic lesions when surgery is not indicated. You can read further details here
InspireMD Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $22.20 on 02/11/21, with the lowest value was $3.60 for the same time period, recorded on 07/27/21.
InspireMD Inc. (NSPR) full year performance was -20.76%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, InspireMD Inc. shares are logging -81.22% during the 52-week period from high price, and 15.83% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.60 and $22.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3047017 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the InspireMD Inc. (NSPR) recorded performance in the market was -23.34%, having the revenues showcasing -8.62% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 31.40M, as it employees total of 45 workers.
Specialists analysis on InspireMD Inc. (NSPR)
During the last month, 2 analysts gave the InspireMD Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.53, with a change in the price was noted -1.04. In a similar fashion, InspireMD Inc. posted a movement of -19.26% for the period of last 100 days, recording 421,828 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NSPR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: InspireMD Inc. (NSPR)
Raw Stochastic average of InspireMD Inc. in the period of last 50 days is set at 51.72%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 45.08%. In the last 20 days, the company’s Stochastic %K was 19.03% and its Stochastic %D was recorded 11.14%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -23.34%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -52.81%, alongside a downfall of -20.76% for the period of the last 12 months. The shares increased approximately by 0.51% in the 7-day charts and went up by -4.39% in the period of the last 30 days. Common stock shares were lifted by -8.62% during last recorded quarter.